Skip to main content

Rheumatoid Arthritis

Dr. John Cush
@RheumNow
Not All Pain in Rheumatic Disease is Inflammatory In a session at the Global Rheumatology Summit, Dr. Daniel Clauw, an expert on the topic, explained that fibromyalgia can occur in isolation in a “top-down” fashion, or can be secondary to inflammatory autoimmune diseases in a https://t.co/AMUm52SKsB
Dr. John Cush
@RheumNow
CAR T Gets the Spotlight. Are We Missing the B Cells That Matter? CAR T is having its moment in rheumatology. But William Robinson’s presentation at ACR Convergence 2026 raised a question I find even more compelling: are we failing to eliminate the right B cells with therapies https://t.co/uta77oaayo
Dr. John Cush
@RheumNow
Falls Hide in Plain Sight in Rheumatic Disease A patient with arthritis pitches forward onto her knees and wrists while bending to grab something. Another time she tries to get up and lands on the bed. Another time she uses a chair to lower herself to the floor. By the World https://t.co/kmmaRxhII0
Dr. John Cush
@RheumNow
Is It Still Inflammation? A 34 year old female has axSpA. Her CRP is 3, her MRI is quiet, and her BASDAI is 7. She has tried two biologics and is asking about a third. Before we write that prescription, #ACR26 challenges us to ask a different question: is it still inflammation? https://t.co/fLGgnBCXS8
Dr. John Cush
@RheumNow
Beyond HLA-B27: Anti-14-3-3eta Autoantibodies as a Candidate Marker in axSpA 14-3-3 proteins are a conserved family of seven isoforms with diverse cellular functions, found predominantly intracellularly. The 14-3-3eta isoform has been studied as a proinflammatory mediator in RA https://t.co/tErmfDBy1r
Dr. John Cush
@RheumNow
Pre-RA: Antibodies Sort the Risk, Ultrasound Erosions Flag Severity Three ACR 2026 abstracts from the Leeds CCP cohort tested how to triage anti-CCP positive individuals with musculoskeletal symptoms. Serology and a few clinical items carried the prediction, while ultrasound https://t.co/91HG7xPS3o
Dr. John Cush
@RheumNow
Looking for RA-ILD: 9 Clinical Clues from ANCHOR-RA Which of our RA patients will develop RA-ILD, and how can we better identify these patients? In abstract #2884 at #ACR26 , Dr. Jeffrey Sparks presented findings from ANCHOR-RA trial, a large prospective cross-sectional study https://t.co/P96KAcPmWt
Dr. John Cush
@RheumNow
Pregnancy After CAR-T in Autoimmune Disease: 14 Pregnancies, No Flares The first multicenter series of pregnancies after CAR T-cell therapy for autoimmune disease reports 8 healthy births and no maternal flares. It is the first dataset of its kind, and the numbers are small. https://t.co/uqWz8GeAmX
Dr. John Cush
@RheumNow
Menopause and Rheumatoid Arthritis: Are we asking enough? A study from Mayo Clinic at ACR Convergence, abstract 1849 examines menopause symptom burden in women with and without RA. Using two research datasets, Kristen Young and colleagues conducted a cross-sectional analysis of https://t.co/V3VJXo3z5w
Dr. John Cush
@RheumNow
Beyond HLA-B27: Anti-14-3-3eta Autoantibodies as a Candidate Marker in axSpA 14-3-3 proteins are a conserved family of seven isoforms with diverse cellular functions, found predominantly intracellularly. The 14-3-3eta isoform has been studied as a proinflammatory mediator in RA https://t.co/yC4bhtnTCD
Dr. John Cush
@RheumNow
All RA-ILD deserves a trial of immunomodulation The optimum treatment approach in RA-ILD remains an area mired in controversy. This is evident from the contrasting views taken by the 2 recent expert guidelines from ACR and EULAR, which advocate for very different treatment https://t.co/vxr8NDruGI
Dr. John Cush
@RheumNow
Cardiovascular Risk in Rheumatoid Arthritis What is the link between cardiovascular risk and dementia? In abstract 1454, Michelle Allen and colleagues at Mayo Clinic studied 2,483 adults with incident RA diagnosed between 1980 and 2019. Patients were followed for Alzheimer’s https://t.co/JaITrlZXIt
Dr. John Cush
@RheumNow
Beyond Joint Inflammation: Does Early RA Control Prevent Chronic Pain and Fatigue? Could the therapeutic window of opportunity in rheumatoid arthritis extend beyond preventing structural damage to preventing chronic pain, fatigue, and neuroimmune complications? This is the https://t.co/WVSjwIHOAM
Antoni Chan MD (Prof)
@synovialjoints
ACR26 summary, gut joint axis: replenishing TRBV9 CD8 T cells, a dual targeting antibody, calprotectin for gut inflammation, and outcomes of joint gastroenterology and rheumatology meetings. @rheumnow #ACR26 Abstract#1027 Abstract#2941 Abstract#1336 Abstract#2287
Antoni Chan MD (Prof)
@synovialjoints
ACR26 summary, pain in axSpA: nociplastic features in 32.5%, fibromyalgia in 9.3%, and early back pain improvement associated with better outcomes at 52 weeks. @rheumnow #ACR26 Abstract#1337 Abstract#1354 Abstract#0347
Akhil Sood MD, MS
@AkhilSoodMD
Erosions and seronegative RA? Abstract 2932 found anti-MFN1 - IgG a/w with inc risk of radiographic erosions at baseline (OR 3.04) & 2 years (OR 3.24) + the adjusted model - IgA a/w erosive disease at baseline only; higher erosion score at baseline & 2 years @RheumNow #ACR26
sheila
@RHEUMarampa
Single ctr retros study Inadeq response (IR) to DEN 37 pts had IR In IR who developed fractures, incr prev of prior vertebral fractures, older age, low fem BMD, incr GIOP In all IR pts, incr CTx values during DEN tx lack of specific criteria for DEN-IR @RheumNow #ACR26 Abs2957 https://t.co/Oxg2k4OSdT
Mrinalini Dey
@DrMiniDey
In 60 RA patients, grayscale ultrasound correlated with biopsy inflammation in early and refractory disease. Power Doppler correlated only in early RA. Biopsies with high ultrasound scores but little inflammation often showed scar tissue. #2934 @Rheumnow #ACR26
Mrinalini Dey
@DrMiniDey
Higher orosomucoid-1 levels were associated with future difficult-to-treat RA in two cohorts (n=198). Samples were taken years before D2T criteria were met. Independent validation using ELISA showed an AUC of 0.86. #2933 @Rheumnow #ACR26
×